Inventor
GARCIA-ECHEVERRIA CARLOS
FR13 patents
⚠️ This page may combine multiple inventors who share the name “GARCIA-ECHEVERRIA CARLOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
6 patentsUS7667039B2Feb 23, 2010
1,3-dihydro-imidazo [4,5-C] quinolin-2-ones as lipid kinase inhibitors
NOVARTIS AG90 citations97
US7893074B2Feb 22, 2011
2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
NOVARTIS AG55 citations93
US7964592B2Jun 21, 2011
2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
NOVARTIS AG29 citations92
US7326699B2Feb 5, 2008
4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives
NOVARTIS AG28 citations92
US7998972B2Aug 16, 2011
1H-imidazo[4,5-c]quinoline derivatives in the treatment of protein kinase dependent diseases
NOVARTIS AG8 citations84
US7994170B2Aug 9, 2011
1,3-dihydro-imidazo[4,5-C]quinolin-2-ones as lipid kinase inhibitors
NOVARTIS AG12 citations83
GARCIA-ECHEVERRIA CARLOS
4 patentsUS8431592B2Apr 30, 2013
1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase inhibitors
GARCIA-ECHEVERRIA CARLOS13 citations91
US8263590B2Sep 11, 2012
Pyrimidine derivatives
GARCIA-ECHEVERRIA CARLOS19 citations91
US9370508B2Jun 21, 2016
Imidazoquinolines as dual lipid kinase and mTOR inhibitors
GARCIA-ECHEVERRIA CARLOS13 citations78
US9241939B2Jan 26, 2016
Combination of (a) a phosphoinositide 3-kinase inhibitor and (b) a modulator of RAS/RAF/MEK pathway
GARCIA-ECHEVERRIA CARLOS0 citations42